Not Tagged
Not Tagged
['i-spy 2', 'breast', 'i-spy']
dr. from is an investigator in the neoadjuvant i-spy 2 trial. results from lba520 &amp; lba612, the late-breaking abstracts exploring early-stage, high-risk #breastcancer will be presented today at 2023. more on this research: 
Rutgers Cancer Institute of New Jersey is the state’s only NCI-designated Comprehensive Cancer Center and a leader in patient care and cancer research.